In vitro methods for assessment of antibody-mediated tumor immunity.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000912:Antibodies, Neoplasm / Q000032:analysis*; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm / Q000032:analysis*; D001323:Autoantibodies; D002272:Carcinoembryonic Antigen; D002859:Chromium Isotopes; D003168:Complement Fixation Tests; D003165:Complement System Proteins; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D004622:Embryo, Mammalian; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D004854:Herpesvirus 4, Human / Q000276:immunology; D006648:Histocompatibility; D006801:Humans; D007158:Immunologic Techniques / Q000592:standards*; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D009439:Neuraminidase / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D014357:Trypsin / Q000494:pharmacology
D000906:Antibodies; D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D002272:Carcinoembryonic Antigen; D002859:Chromium Isotopes; D003165:Complement System Proteins; D009439:Neuraminidase; D014357:Trypsin